Pharmacological interventions for the treatment of obstructive sleep apnea syndrome

Pharmacological interventions for the treatment of obstructive sleep apnea syndrome

Obstructive Sleep Apnea Syndrome (OSAS) affects 13–33% of males and 6–9% of females globally and poses significant treatment challenges, including poor adherence to Continuous Positive Airway Pressure (CPAP) and residual excessive sleepiness (RES). This review aims to elucidate the emerging interest...

Full description

Bibliographic Details
Main Authors: Jin Liu, Xiaolan Yang, Guangcai Li, Peijun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Medicine
Subjects:
OSAS
pharmacological treatments
respiratory disorder
ESS
CPAP
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1359461/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1359461/full

Similar Items